IBDEI0A8 ; ; 06-AUG-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 06, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13634,1,3,0)
 ;;=3^443.9
 ;;^UTILITY(U,$J,358.3,13634,1,4,0)
 ;;=4^PERIPH VASCULAR DIS
 ;;^UTILITY(U,$J,358.3,13634,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,13635,0)
 ;;=424.1^^83^728^3
 ;;^UTILITY(U,$J,358.3,13635,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13635,1,3,0)
 ;;=3^424.1
 ;;^UTILITY(U,$J,358.3,13635,1,4,0)
 ;;=4^AORTIC VALVE DIS
 ;;^UTILITY(U,$J,358.3,13635,2)
 ;;=^9330
 ;;^UTILITY(U,$J,358.3,13636,0)
 ;;=459.81^^83^728^14
 ;;^UTILITY(U,$J,358.3,13636,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13636,1,3,0)
 ;;=3^459.81
 ;;^UTILITY(U,$J,358.3,13636,1,4,0)
 ;;=4^VENOUS INSUFFICIENCY
 ;;^UTILITY(U,$J,358.3,13636,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,13637,0)
 ;;=411.1^^83^728^2
 ;;^UTILITY(U,$J,358.3,13637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13637,1,3,0)
 ;;=3^411.1
 ;;^UTILITY(U,$J,358.3,13637,1,4,0)
 ;;=4^ANGINA PECTORIS/UNSTABLE
 ;;^UTILITY(U,$J,358.3,13637,2)
 ;;=^7455
 ;;^UTILITY(U,$J,358.3,13638,0)
 ;;=429.2^^83^728^4
 ;;^UTILITY(U,$J,358.3,13638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13638,1,3,0)
 ;;=3^429.2
 ;;^UTILITY(U,$J,358.3,13638,1,4,0)
 ;;=4^ASCVD
 ;;^UTILITY(U,$J,358.3,13638,2)
 ;;=^19738
 ;;^UTILITY(U,$J,358.3,13639,0)
 ;;=414.01^^83^728^6
 ;;^UTILITY(U,$J,358.3,13639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13639,1,3,0)
 ;;=3^414.01
 ;;^UTILITY(U,$J,358.3,13639,1,4,0)
 ;;=4^CAD
 ;;^UTILITY(U,$J,358.3,13639,2)
 ;;=^303281
 ;;^UTILITY(U,$J,358.3,13640,0)
 ;;=401.9^^83^728^9
 ;;^UTILITY(U,$J,358.3,13640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13640,1,3,0)
 ;;=3^401.9
 ;;^UTILITY(U,$J,358.3,13640,1,4,0)
 ;;=4^HYPERTENSION, ESSENTIAL
 ;;^UTILITY(U,$J,358.3,13640,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,13641,0)
 ;;=394.0^^83^728^11
 ;;^UTILITY(U,$J,358.3,13641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13641,1,3,0)
 ;;=3^394.0
 ;;^UTILITY(U,$J,358.3,13641,1,4,0)
 ;;=4^MITRAL STENOSIS
 ;;^UTILITY(U,$J,358.3,13641,2)
 ;;=^78404
 ;;^UTILITY(U,$J,358.3,13642,0)
 ;;=285.9^^83^729^1
 ;;^UTILITY(U,$J,358.3,13642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13642,1,3,0)
 ;;=3^285.9
 ;;^UTILITY(U,$J,358.3,13642,1,4,0)
 ;;=4^ANEMIA
 ;;^UTILITY(U,$J,358.3,13642,2)
 ;;=^7007
 ;;^UTILITY(U,$J,358.3,13643,0)
 ;;=266.2^^83^729^2
 ;;^UTILITY(U,$J,358.3,13643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13643,1,3,0)
 ;;=3^266.2
 ;;^UTILITY(U,$J,358.3,13643,1,4,0)
 ;;=4^B12 & FOLATE ANEMIA
 ;;^UTILITY(U,$J,358.3,13643,2)
 ;;=^87347
 ;;^UTILITY(U,$J,358.3,13644,0)
 ;;=272.0^^83^729^3
 ;;^UTILITY(U,$J,358.3,13644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13644,1,3,0)
 ;;=3^272.0
 ;;^UTILITY(U,$J,358.3,13644,1,4,0)
 ;;=4^CHOLESTEROL (HYPER)
 ;;^UTILITY(U,$J,358.3,13644,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,13645,0)
 ;;=250.00^^83^729^6
 ;;^UTILITY(U,$J,358.3,13645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13645,1,3,0)
 ;;=3^250.00
 ;;^UTILITY(U,$J,358.3,13645,1,4,0)
 ;;=4^DIABETES MEL W/O COMP, TYPE II
 ;;^UTILITY(U,$J,358.3,13645,2)
 ;;=^33605
 ;;^UTILITY(U,$J,358.3,13646,0)
 ;;=250.02^^83^729^5
 ;;^UTILITY(U,$J,358.3,13646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13646,1,3,0)
 ;;=3^250.02
 ;;^UTILITY(U,$J,358.3,13646,1,4,0)
 ;;=4^DIAB MEL W/O COMP, TYPE II UNCONT
 ;;^UTILITY(U,$J,358.3,13646,2)
 ;;=^295704
 ;;^UTILITY(U,$J,358.3,13647,0)
 ;;=272.4^^83^729^9
 ;;^UTILITY(U,$J,358.3,13647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13647,1,3,0)
 ;;=3^272.4
 ;;^UTILITY(U,$J,358.3,13647,1,4,0)
 ;;=4^HYPERLIPIDEMIA
 ;;^UTILITY(U,$J,358.3,13647,2)
 ;;=^87281
 ;;^UTILITY(U,$J,358.3,13648,0)
 ;;=244.9^^83^729^10
 ;;^UTILITY(U,$J,358.3,13648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13648,1,3,0)
 ;;=3^244.9
 ;;^UTILITY(U,$J,358.3,13648,1,4,0)
 ;;=4^HYPOTHYROIDISM
 ;;^UTILITY(U,$J,358.3,13648,2)
 ;;=^123752
 ;;^UTILITY(U,$J,358.3,13649,0)
 ;;=250.01^^83^729^4
 ;;^UTILITY(U,$J,358.3,13649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13649,1,3,0)
 ;;=3^250.01
 ;;^UTILITY(U,$J,358.3,13649,1,4,0)
 ;;=4^DIAB MEL W/O COMP, TYPE I
 ;;^UTILITY(U,$J,358.3,13649,2)
 ;;=^33586
 ;;^UTILITY(U,$J,358.3,13650,0)
 ;;=790.6^^83^729^8
 ;;^UTILITY(U,$J,358.3,13650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13650,1,3,0)
 ;;=3^790.6
 ;;^UTILITY(U,$J,358.3,13650,1,4,0)
 ;;=4^HYPERGLYCEMIA
 ;;^UTILITY(U,$J,358.3,13650,2)
 ;;=^87228
 ;;^UTILITY(U,$J,358.3,13651,0)
 ;;=278.01^^83^729^11
 ;;^UTILITY(U,$J,358.3,13651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13651,1,3,0)
 ;;=3^278.01
 ;;^UTILITY(U,$J,358.3,13651,1,4,0)
 ;;=4^OBESITY, MORBID
 ;;^UTILITY(U,$J,358.3,13651,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,13652,0)
 ;;=286.59^^83^729^7
 ;;^UTILITY(U,$J,358.3,13652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13652,1,3,0)
 ;;=3^286.59
 ;;^UTILITY(U,$J,358.3,13652,1,4,0)
 ;;=4^HEMOR D/O DUE TO CIRC ANTICOAG
 ;;^UTILITY(U,$J,358.3,13652,2)
 ;;=^340504
 ;;^UTILITY(U,$J,358.3,13653,0)
 ;;=268.9^^83^729^12
 ;;^UTILITY(U,$J,358.3,13653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13653,1,3,0)
 ;;=3^268.9
 ;;^UTILITY(U,$J,358.3,13653,1,4,0)
 ;;=4^VITAMIN D DEFICIENCY NOS
 ;;^UTILITY(U,$J,358.3,13653,2)
 ;;=^126968
 ;;^UTILITY(U,$J,358.3,13654,0)
 ;;=389.9^^83^730^7
 ;;^UTILITY(U,$J,358.3,13654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13654,1,3,0)
 ;;=3^389.9
 ;;^UTILITY(U,$J,358.3,13654,1,4,0)
 ;;=4^HEARING LOSS
 ;;^UTILITY(U,$J,358.3,13654,2)
 ;;=^54552
 ;;^UTILITY(U,$J,358.3,13655,0)
 ;;=380.4^^83^730^8
 ;;^UTILITY(U,$J,358.3,13655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13655,1,3,0)
 ;;=3^380.4
 ;;^UTILITY(U,$J,358.3,13655,1,4,0)
 ;;=4^IMPACTED CERUMEN
 ;;^UTILITY(U,$J,358.3,13655,2)
 ;;=^62061
 ;;^UTILITY(U,$J,358.3,13656,0)
 ;;=382.9^^83^730^9
 ;;^UTILITY(U,$J,358.3,13656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13656,1,3,0)
 ;;=3^382.9
 ;;^UTILITY(U,$J,358.3,13656,1,4,0)
 ;;=4^OTITIS MEDIA
 ;;^UTILITY(U,$J,358.3,13656,2)
 ;;=^123967
 ;;^UTILITY(U,$J,358.3,13657,0)
 ;;=365.11^^83^730^5
 ;;^UTILITY(U,$J,358.3,13657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13657,1,3,0)
 ;;=3^365.11
 ;;^UTILITY(U,$J,358.3,13657,1,4,0)
 ;;=4^GLAUCOMA,PRIMARY OPEN ANGLE
 ;;^UTILITY(U,$J,358.3,13657,2)
 ;;=^51203
 ;;^UTILITY(U,$J,358.3,13658,0)
 ;;=372.72^^83^730^10
 ;;^UTILITY(U,$J,358.3,13658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13658,1,3,0)
 ;;=3^372.72
 ;;^UTILITY(U,$J,358.3,13658,1,4,0)
 ;;=4^SUBCONJUNCTIVAL HEMORRHAGE
 ;;^UTILITY(U,$J,358.3,13658,2)
 ;;=^27538
 ;;^UTILITY(U,$J,358.3,13659,0)
 ;;=365.70^^83^730^1
 ;;^UTILITY(U,$J,358.3,13659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13659,1,3,0)
 ;;=3^365.70
 ;;^UTILITY(U,$J,358.3,13659,1,4,0)
 ;;=4^GLAUCOMA STAGE NOS
 ;;^UTILITY(U,$J,358.3,13659,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,13660,0)
 ;;=365.71^^83^730^3
 ;;^UTILITY(U,$J,358.3,13660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13660,1,3,0)
 ;;=3^365.71
 ;;^UTILITY(U,$J,358.3,13660,1,4,0)
 ;;=4^GLAUCOMA,MILD STAGE
 ;;^UTILITY(U,$J,358.3,13660,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,13661,0)
 ;;=365.72^^83^730^4
 ;;^UTILITY(U,$J,358.3,13661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13661,1,3,0)
 ;;=3^365.72
 ;;^UTILITY(U,$J,358.3,13661,1,4,0)
 ;;=4^GLAUCOMA,MODERATE STAGE
 ;;^UTILITY(U,$J,358.3,13661,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,13662,0)
 ;;=365.73^^83^730^6
 ;;^UTILITY(U,$J,358.3,13662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13662,1,3,0)
 ;;=3^365.73
 ;;^UTILITY(U,$J,358.3,13662,1,4,0)
 ;;=4^GLAUCOMA,SEVERE STAGE
 ;;^UTILITY(U,$J,358.3,13662,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,13663,0)
 ;;=365.74^^83^730^2
 ;;^UTILITY(U,$J,358.3,13663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13663,1,3,0)
 ;;=3^365.74
 ;;^UTILITY(U,$J,358.3,13663,1,4,0)
 ;;=4^GLAUCOMA,INDETERM STAGE
 ;;^UTILITY(U,$J,358.3,13663,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,13664,0)
 ;;=571.5^^83^731^1
 ;;^UTILITY(U,$J,358.3,13664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13664,1,3,0)
 ;;=3^571.5
 ;;^UTILITY(U,$J,358.3,13664,1,4,0)
 ;;=4^CIRRHOSIS OF LIVER
 ;;^UTILITY(U,$J,358.3,13664,2)
 ;;=^24731
 ;;^UTILITY(U,$J,358.3,13665,0)
 ;;=530.81^^83^731^2
 ;;^UTILITY(U,$J,358.3,13665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13665,1,3,0)
 ;;=3^530.81
 ;;^UTILITY(U,$J,358.3,13665,1,4,0)
 ;;=4^ESOPHAGEAL REFLUX (GERD)
 ;;^UTILITY(U,$J,358.3,13665,2)
 ;;=^295749
 ;;^UTILITY(U,$J,358.3,13666,0)
 ;;=558.9^^83^731^4
 ;;^UTILITY(U,$J,358.3,13666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13666,1,3,0)
 ;;=3^558.9
 ;;^UTILITY(U,$J,358.3,13666,1,4,0)
 ;;=4^GASTROENTERITIS/COLITIS, NONINFECT
 ;;^UTILITY(U,$J,358.3,13666,2)
 ;;=^87311
 ;;^UTILITY(U,$J,358.3,13667,0)
 ;;=564.1^^83^731^8
 ;;^UTILITY(U,$J,358.3,13667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13667,1,3,0)
 ;;=3^564.1
 ;;^UTILITY(U,$J,358.3,13667,1,4,0)
 ;;=4^IRRITABLE COLON
 ;;^UTILITY(U,$J,358.3,13667,2)
 ;;=^65682
 ;;^UTILITY(U,$J,358.3,13668,0)
 ;;=211.3^^83^731^9
 ;;^UTILITY(U,$J,358.3,13668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13668,1,3,0)
 ;;=3^211.3
 ;;^UTILITY(U,$J,358.3,13668,1,4,0)
 ;;=4^POLYPS, COLON/LG BOWEL (BENIGN NEO
 ;;^UTILITY(U,$J,358.3,13668,2)
 ;;=^13295
 ;;^UTILITY(U,$J,358.3,13669,0)
 ;;=533.90^^83^731^10
 ;;^UTILITY(U,$J,358.3,13669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13669,1,3,0)
 ;;=3^533.90
 ;;^UTILITY(U,$J,358.3,13669,1,4,0)
 ;;=4^ULCER, PEPTIC
 ;;^UTILITY(U,$J,358.3,13669,2)
 ;;=^93051
 ;;^UTILITY(U,$J,358.3,13670,0)
 ;;=535.00^^83^731^3
 ;;^UTILITY(U,$J,358.3,13670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13670,1,3,0)
 ;;=3^535.00
 ;;^UTILITY(U,$J,358.3,13670,1,4,0)
 ;;=4^GASTRITIS, ACUTE
 ;;^UTILITY(U,$J,358.3,13670,2)
 ;;=^270169
 ;;^UTILITY(U,$J,358.3,13671,0)
 ;;=070.54^^83^731^6
 ;;^UTILITY(U,$J,358.3,13671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13671,1,3,0)
 ;;=3^070.54
 ;;^UTILITY(U,$J,358.3,13671,1,4,0)
 ;;=4^HEPATITIS C,CHRONIC,W/O COMA
 ;;^UTILITY(U,$J,358.3,13671,2)
 ;;=^303252
 ;;^UTILITY(U,$J,358.3,13672,0)
 ;;=553.9^^83^731^7
 ;;^UTILITY(U,$J,358.3,13672,1,0)
 ;;=^358.31IA^4^2
